Drug Approval | February 03, 2022
USFDA approves first generic of Restasis
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
It is the first approved generic and is eligible for 180 days of Competitive Generic Therapy exclusivity
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
A total of 12 generic medicines have been included in the list
Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
Floods had forced the plans in Mahad to shut down
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
Subscribe To Our Newsletter & Stay Updated
